- Home
- LCNB vs SGMO Comparison
LCNB vs SGMO Comparison
Compare LCNB & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCNB
- SGMO
- Stock Information
- Founded
- LCNB 1877
- SGMO 1995
- Country
- LCNB United States
- SGMO United States
- Employees
- LCNB N/A
- SGMO N/A
- Industry
- LCNB Major Banks
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LCNB Finance
- SGMO Health Care
- Exchange
- LCNB Nasdaq
- SGMO Nasdaq
- Market Cap
- LCNB 216.4M
- SGMO 242.0M
- IPO Year
- LCNB N/A
- SGMO 2000
- Fundamental
- Price
- LCNB $14.52
- SGMO $0.92
- Analyst Decision
- LCNB
- SGMO Buy
- Analyst Count
- LCNB 0
- SGMO 6
- Target Price
- LCNB N/A
- SGMO $5.17
- AVG Volume (30 Days)
- LCNB 23.6K
- SGMO 3.9M
- Earning Date
- LCNB 04-29-2025
- SGMO 05-08-2025
- Dividend Yield
- LCNB 6.03%
- SGMO N/A
- EPS Growth
- LCNB N/A
- SGMO N/A
- EPS
- LCNB 0.97
- SGMO N/A
- Revenue
- LCNB $79,237,000.00
- SGMO $52,291,000.00
- Revenue This Year
- LCNB N/A
- SGMO N/A
- Revenue Next Year
- LCNB $7.21
- SGMO N/A
- P/E Ratio
- LCNB $15.05
- SGMO N/A
- Revenue Growth
- LCNB 13.71
- SGMO N/A
- 52 Week Low
- LCNB $12.42
- SGMO $0.30
- 52 Week High
- LCNB $17.92
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- LCNB 41.94
- SGMO 39.24
- Support Level
- LCNB $14.35
- SGMO $0.94
- Resistance Level
- LCNB $15.22
- SGMO $1.05
- Average True Range (ATR)
- LCNB 0.42
- SGMO 0.11
- MACD
- LCNB -0.04
- SGMO 0.01
- Stochastic Oscillator
- LCNB 22.86
- SGMO 44.21
About LCNB LCNB Corporation
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections, and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.